JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berlin, M.
Right arrow Articles by Rylander, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berlin, M.
Right arrow Articles by Rylander, R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 146, Issue 2, 236-240, 1964
Copyright © 1964 by American Society for Pharmacology and Experimental Therapeutics


INCREASED BRAIN UPTAKE OF MERCURY INDUCED BY 2,3-DIMERCAPTO-PROPANOL (BAL) IN MICE EXPOSED TO PHENYLMERCURIC ACETATE

M. Berlin 1 and R. Rylander 1

1 Institute of Hygiene, Karolinska Institutet, and the Department of General Hygiene, National Institute of Public Health Stockholm, Sweden

The effect of BAL (0.4 mg/kg) on the body distribution of mercury in mice given a single dose of phenyl-Hg203 acetate (0.5 mg of Hg/kg) was studied by autoradiography of sagittal whole-body sections. It was shown that BAL effected a redistribution of the body mercury load; this included a persistent increase in mercury concentration in brain, liver and muscle, and a transient decrease in the kidney, for the 16-day period studied.

A second series of mice was given daily injections of phenyl-Hg203 acetate (1 mg of Hg/kg) for 16 days; half also got 3 mg of BAL/kg daily. Scintillation counts of brains of BAL-treated mice showed twice as much radioactivity after 16 days as in brains of control animals.

If the object in treatment of chronic phenylmercuric poisoning is to diminish brain mercury load, the use of BAL must be re-examined.

Accepted on July 24, 1964







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1964 by the American Society for Pharmacology and Experimental Therapeutics.